Physician profile
Mark D Dykowski
NPI 1487635637
$781.57
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.17 · 2020: $49.87 · 2021: $94.21 · 2022: $316 · 2023: $200 · 2024: $23.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.01 | 2020-2022 | |
| Organon LLC | $95.85 | 2022-2023 | Nexplanon |
| Daiichi Sankyo INC. | $83.33 | 2019-2022 | |
| Hologic Sales and Service, LLC | $52.91 | 2023-2024 | Novasure, Coolseal Generator, Acessa Provu System |
| Covidien Lp | $47.69 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $38.48 | 2022-2023 | |
| Coopersurgical, INC. | $35.52 | 2022-2023 | |
| Therapeuticsmd, INC. | $33.15 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $31.41 | 2019 | |
| Exeltis, USA INC. | $29.88 | 2022 | |
| Pfizer INC. | $26.84 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $25.65 | 2023 | Myfembree |
| Meditrina | $23.00 | 2023 | |
| Merck Sharp & Dohme LLC | $22.21 | 2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $21.30 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $19.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.09 | 2022 | |
| Dysis Medical, INC. | $16.73 | 2021 | |
| Acessa Health INC. | $15.60 | 2019 | |
| Medtronic, INC. | $15.38 | 2021 | |
| Avion Pharmaceuticals | $14.14 | 2022 | |
| Myriad Women'S Health, INC. | $13.27 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dykowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.